temozolomide has been researched along with acriflavine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alomari, S; Brem, H; Cecia, A; Darjee, N; Domb, AJ; Gorelick, NL; Mangraviti, A; Rottenberg, Y; Serra, R; Shapira-Furman, T; Tyler, B | 1 |
1 other study(ies) available for temozolomide and acriflavine
| Article | Year |
|---|---|
Combined intracranial Acriflavine, temozolomide and radiation extends survival in a rat glioma model.
Topics: Absorbable Implants; Acriflavine; Animals; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Drug Implants; Glioma; Polymers; Radiotherapy Dosage; Rats; Rats, Inbred F344; Survival Rate; Temozolomide; Xenograft Model Antitumor Assays | 2022 |